ADMA - ADMA BIOLOGICS, INC.

QQQ $ 433.04 $ 1.75 (0.41 %)

DIA $ 383.81 $ 1.49 (0.39 %)

SPY $ 510.06 $ 1.80 (0.35 %)

TLT $ 88.99 $ 0.74 (0.84 %)

GLD $ 216.18 $ -0.44 (-0.2 %)

Previous Close

$ 6.58

Open

$ 6.60

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 6.50 - $ 6.60

52 Week Range

$ 3.06 - $ 6.76

Volume

1,129,067

Average Volume

Market Cap

1.47B

Beta (5Y Monthly)

$ 0.63

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-28-2024	12-31-2023	10-K
2	11-08-2023	09-30-2023	10-Q
3	08-09-2023	06-30-2023	10-Q
4	05-10-2023	03-31-2023	10-Q
5	03-23-2023	12-31-2022	10-K
6	11-09-2022	09-30-2022	10-Q
7	08-10-2022	06-30-2022	10-Q
8	05-11-2022	03-31-2022	10-Q
9	03-24-2022	12-31-2021	10-K
10	11-10-2021	09-30-2021	10-Q
11	08-11-2021	06-30-2021	10-Q
12	05-12-2021	03-31-2021	10-Q
13	03-25-2021	12-31-2020	10-K
14	11-05-2020	09-30-2020	10-Q
15	08-05-2020	06-30-2020	10-Q
16	05-06-2020	03-31-2020	10-Q
17	03-13-2020	12-31-2019	10-K
18	11-06-2019	09-30-2019	10-Q
19	08-08-2019	06-30-2019	10-Q
20	05-08-2019	03-31-2019	10-Q
21	03-13-2019	12-31-2018	10-K
22	11-09-2018	09-30-2018	10-Q
23	08-10-2018	06-30-2018	10-Q
24	05-14-2018	03-31-2018	10-Q
25	03-29-2018	12-31-2017	10-K
26	11-03-2017	09-30-2017	10-Q
27	08-11-2017	06-30-2017	10-Q
28	05-12-2017	03-31-2017	10-Q
29	02-24-2017	12-31-2016	10-K
30	11-10-2016	09-30-2016	10-Q
31	08-12-2016	06-30-2016	10-Q
32	05-13-2016	03-31-2016	10-Q
33	03-23-2016	12-31-2015	10-K
34	11-10-2015	09-30-2015	10-Q
35	08-11-2015	06-30-2015	10-Q
36	05-12-2015	03-31-2015	10-Q
37	03-09-2015	12-31-2014	10-K
38	11-10-2014	09-30-2014	10-Q
39	08-11-2014	06-30-2014	10-Q
40	05-12-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

A Closer Look at 6 Analyst Recommendations...
03/26/2024 12:00:32

HC Wainwright & Co. Reiterates Buy on ADMA...
03/26/2024 10:24:44

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates ADMA Biologics (NASDAQ:ADMA) with a Buy and raises the price t...

ADMA Biologics Reports FDA Approvals Of Ex...
03/11/2024 11:01:14

The room temperature approval applies to all existing ASCENIV and BIVIGAM lots currently in the commercial supply chain as well...

Piper Sandler Maintains Buy on ADMA Biolog...
03/01/2024 14:40:14

Piper Sandler analyst Anthony Petrone maintains ADMA Biologics (NASDAQ:ADMA) with a Buy and raises the price target from $9 ...

Cantor Fitzgerald Maintains Overweight on ...
02/29/2024 18:51:41

Cantor Fitzgerald analyst Kristen Kluska maintains ADMA Biologics (NASDAQ:ADMA) with a Overweight and raises the price targe...

Forecasting The Future: 4 Analyst Projecti...
02/29/2024 15:01:01

HC Wainwright & Co. Reiterates Buy on ADMA...
02/29/2024 14:05:50

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates ADMA Biologics (NASDAQ:ADMA) with a Buy and maintains $6 price...

ADMA Biologics Sees FY24 And FY25 Total Re...
02/28/2024 21:56:56

Recap: ADMA Biologics Q4 Earnings
02/28/2024 21:30:30

ADMA Biologics Q4 2023 Adj EPS $0.04 Beats...
02/28/2024 21:28:19

ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.03 ...

ADMA Biologics Says Brian Lenz, Executive ...
02/28/2024 21:27:54

Grossman has been appointed as Interim Chief Financial Officer, effective April 1, 2024. The Company has initiated an executive...

Earnings Scheduled For February 28, 2024
02/28/2024 11:24:02

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

Earnings Preview For ADMA Biologics
02/27/2024 19:01:15

ADMA Biologics Announced Successful Initia...
02/21/2024 12:14:41

ADMAlytics Combines Generative AI and Machine Learning to Optimize Production Processes ADMA Successfully Utilized ADMAlytic...

Cracking The Code: Understanding Analyst R...
01/22/2024 15:00:25

Mizuho Maintains Buy on ADMA Biologics, Ra...
01/22/2024 14:15:04

Mizuho analyst Anthony Petrone maintains ADMA Biologics (NASDAQ:ADMA) with a Buy and raises the price target from $7 to $9.

HC Wainwright & Co. Maintains Buy on ADMA ...
01/09/2024 12:09:47

HC Wainwright & Co. analyst Raghuram Selvaraju maintains ADMA Biologics (NASDAQ:ADMA) with a Buy and raises the price ta...

ADMA Biologics' 4Q 2023 Preliminary Unaudi...
01/08/2024 13:18:50

2024-2025 Financial Guidance: FY 2024-2025 Total Revenue expected to be in the range of $320 Million to $370 Million, respec...

Cantor Fitzgerald Reiterates Overweight on...
12/19/2023 17:10:08

Cantor Fitzgerald analyst Kristen Kluska reiterates ADMA Biologics (NASDAQ:ADMA) with a Overweight and maintains $6 price ta...

ADMA Biologics Announces $135M Non-Dilutiv...
12/18/2023 21:07:36

New $135 Million Credit Facility Replaces Existing $159 Million Credit Facility, a 15% Decrease in Total Debt Further Supports ...